Foundation for Mitochondrial Medicine

AA

A A
Foundation for Mitochondrial Medicine
9th of May 2017

SE Mitochondrial Medicine Symposium Highlights Ground-Breaking Research

Southeast Mitochondrial Medicine Symposium Highlights Ground-Breaking Research for Neurologic Diseases In early April, The Foundation for Mitochondrial Medicine paired with the other leading mitochondrial disease research/educational organizations, the United Mitochondrial Disease Foundation (UMDF), to jointly sponsor the Southeast Regional Symposium on Mitochondrial Medicine in Birmingham, Ala. The symposium: “Understanding Mitochondrial Disease and Mitochondrial Dysfunction:  Opportunities […]

Read More

7th of April 2017

Thought leaders in mitochondrial disease & science in Birmingham #SEmitosymposium

Thought leaders in mitochondrial disease, science and organizational leadership meet together in Birmingham April on April 7th  for the Mitochondrial Medicine Southeast Symposium. On April 8th, patient families and advocates come together for learning and resource sharing. FMM and UMDF are proud to partner together to provide this opportunity for learning and sharing. #SEmitosymposium press […]

Read More

17th of November 2016

Mitochondrial Myopathy Clinical Trial teleconference

12/6/2016 teleconference discussion of data from Stealth BioTherapeutics’ Mitochondrial Myopathy clinical trial. This summer, Stealth BioTherapeutics (Stealth BT) shared preliminary positive data from the MMPOWER study. The study purpose was to evaluate safety and efficacy of elamipretide (previously known as Bendavia) in adults with primary mitochondrial myopathy and genetically confirmed mitochondrial disease. Mitochondrial myopathy is primarily […]

Read More

27th of February 2014

Alzheimer’s Drug Discovery Foundation and Foundation for Mitochondrial Medicine Partner to Support Novel Research for Mitochondrial-Directed Therapies

Research could lead to development of new therapies to treat a variety of mitochondrial diseases, including Autism, Alzheimer’s, Parkinson’s and Lou Gehrig’s disease ATLANTA and NEW YORK, February 26, 2014 – The Alzheimer’s Drug Discovery Foundation (ADDF) and the Foundation for Mitochondrial Medicine (FMM) announced today that they have awarded $200,000 in funding to James […]

Read More

14th of June 2013

Planning to Run the Peachtree Road Race in Atlanta?

This year make your accomplishment something more by becoming a Hope Flies Athlete! In addition to helping raise funds and awareness for mitochondrial disease, you’ll have the opportunity to participate in Group Training Runs with elite athletes from the Atlanta Women’s Marathon League, including the winner of the 2013 Publix Marathon, Jill Horst. Group runs […]

Read More

13th of June 2013

FMM Celebrates Newest Atlanta Braves Player, Kyle Wren!

Kudos to Kyle Wren, who was recently drafted to play baseball for the Atlanta Braves!  As the son of FMM board member Frank Wren and the brother of FMM ambassador Colby Wren, Kyle is an integral part of the FMM team, and we are so very proud of his success.  Best of luck to Kyle […]

Read More

12th of June 2013

2012 Annual Report

On behalf of our Board of Directors, and the 1 in 2,500 affected by mitochondrial disease, we thank those who continue to support the Foundation for Mitochondrial Medicine.  2012 was filled with much success including research progress, 4 new regional fundraising and awareness events, the launch of our new Hope Flies Health Series and more. […]

Read More

11th of June 2013

Become An All-Inclusive Multi-Event Hope Flies Partner

Hope Flies is the Foundation for Mitochondrial Medicine’s (FMM’s) signature fundraising program dedicated to celebrating hope and raising significant funds and awareness for the most promising mitochondrial disease research and treatments. Hope Flies fundraising events are held in various locations across the country and come in different shapes and sizes. Becoming an All-Inclusive Multi-Event Hope […]

Read More

Stay Connected with FMM

  • This field is for validation purposes and should be left unchanged.
Translate »